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Microglia are important cells in the brain that can acquire different morphological and
functional phenotypes dependent on the local situation they encounter. Knowledge on
the region-specific gene signature of microglia may hold valuable clues for microglial
functioning in health and disease, e.g., Parkinson’s disease (PD) in which microglial
phenotypes differ between affected brain regions. Therefore, we here investigated
whether regional differences exist in gene expression profiles of microglia that are
isolated from healthy rat brain regions relevant for PD. We used an optimized isolation
protocol based on a rapid isolation of microglia from discrete rat gray matter regions
using density gradients and fluorescent-activated cell sorting. Application of the present
protocol followed by gene expression analysis enabled us to identify subtle differences
in region-specific microglial expression profiles and show that the genetic profile of
microglia already differs between different brain regions when studied under control
conditions. As such, these novel findings imply that brain region-specific microglial
gene expression profiles exist that may contribute to the region-specific differences in
microglia responsivity during disease conditions, such as seen in, e.g., PD.
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Introduction
Microglia are the primary, innate immune cells of the central nervous system (CNS) respon-
sible for safeguarding and maintenance of brain homeostasis. By constantly surveying their
microenvironment, microglia can quickly respond to a disturbed homeostasis caused, by e.g.,
pathogens or injury. Under such conditions, microglia undergo typical morphological and func-
tional alterations and become engaged in processes like phagocytosis, cytokine production, antigen
presentation and/or cell proliferation (Nimmerjahn et al., 2005; Hanisch and Kettenmann, 2007;
Kettenmann et al., 2011; Doorn et al., 2014a).
Abbreviations: α-synuclein, alpha-synuclein; Aβ, amyloid-beta; AON, anterior olfactory nucleus; CA, cornus ammonis;
GFAP, glial ﬁbrillary acidic protein; HC, hippocampus; HPtau, hyperphosphorylated tau; Iba1, ionized calcium binding
adaptor molecule 1; IL, interleukin; iLBD, incidental Lewy body disease; IR, immunoreactivity; LBs, Lewy bodies; LNs,
Lewy neurites; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NFT, neuroﬁbrillary tangles; OB, olfactory bulb; PD,
Parkinson’s disease; SN, substantia nigra; TLR, toll like receptor; TNFα, tumor necrosis factor-alpha.
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Although prior studies have suggested that microglial activa-
tion is largely detrimental in the context of homeostatic brain
disturbances, it is now well accepted that microglia can also
beneﬁt CNS function and provide neuroprotection, shape neu-
ronal circuits and promote axonal regeneration (Ekdahl et al.,
2003; Walter and Neumann, 2009; Welser et al., 2010; Czeh et al.,
2011; Wake et al., 2013). In addition, while knowledge on gen-
eral microglial morphology and function is well established, only
recently has it become clear that microglial activity may be
region-speciﬁc. Hence, previous views on microglia as a rather
uniform cell population present throughout the brain, have
now been replaced by the concept that these cells can acquire
speciﬁc phenotypes depending on their region-speciﬁc environ-
ment (Lucin andWyss-Coray, 2009; Ransohoﬀ and Perry, 2009;
Olah et al., 2011).
Besides regional diﬀerences in microglial density, which are
positively correlated with, e.g., diﬀerential sensitivity to LPS-
induced neurotoxicity (Kim et al., 2000), microglia display a
region-dependent diversity in their surface markers expres-
sion (Lawson et al., 1990; Mittelbronn et al., 2001; De Haas et al.,
2008; Buschmann et al., 2012). In addition, injection of inter-
feron gamma (IFN-γ) into the brain caused a signiﬁcant
upregulation of major histocompatibility complex II (MHC
II) molecules by microglia in the brainstem but not in the
HC (Peng et al., 1998; Olah et al., 2011). Although such overt
region-speciﬁc microglial responsiveness could be a mere conse-
quence of diﬀerences in the local microenvironment, microglia
isolated from diﬀerent brain regions also present a dis-
tinct inﬂammatory proﬁle at basal conditions as well as fol-
lowing endotoxin stimulation in vitro. This suggest that at
least some of these traits are inherent to the microglia cells
themselves, e.g., M1 or M2 type microglia (Ren et al., 1999;
Xie et al., 2003).
Microglial diversity has also raised interest in their role in
various neurodegenerative diseases, including PD (McGeer et al.,
1988; Perry et al., 2010; Halliday and Stevens, 2011; Doorn et al.,
2012; Hirsch et al., 2012). Recent data have shown that
α-synuclein pathology spreads throughout the brain and
aﬀects several brain regions in PD patients (Braak et al., 2004),
including the SN, OB, brainstem, limbic system and neocortex,
in a disease-stage dependent manner (Braak and Braak, 2000;
Amino et al., 2005; Orimo et al., 2007; Dickson et al., 2009;
Jellinger, 2011). Microglia have been proposed to contribute
to this diﬀerential, and evolving pattern of neuropathology
that may underlie at least some of the motor and non-motor
symptoms in PD (Doorn et al., 2014b). Besides the iden-
tiﬁcation of activated microglia in the SN, i.e., a classical
neuropathological PD site, microglial activation also occurs in
non-dopaminergic regions like the OB and HC, notably regions
where no or little neuronal loss occurs in PD (Imamura et al.,
2003; McGeer and McGeer, 2008; Doorn et al., 2013, 2014b). In
addition, we recently observed expression of microglial Toll-like
receptor-2 (TLR2), that is involved in α-synuclein-mediated
microglial activation, to be diﬀerent between the HC and SN of
PD patients (Kim et al., 2013; Doorn et al., 2014b), consistent
with the concept of region-speciﬁc microglial phenotypes in
human tissue.
The presence and proﬁle of microglial surface markers not
only diﬀer between diﬀerent brain regions in healthy control
mice, also a diﬀerential responsiveness to various stimuli has been
documented (Peng et al., 1998; Vroon et al., 2007; De Haas et al.,
2008; Olah et al., 2011; Watson et al., 2012). Prior to studying
region-speciﬁc diﬀerences in microglial expression proﬁles in a
disease model, we here study whether gene expression proﬁles
of rat microglia are already region-speciﬁc under baseline con-
ditions. This is of importance as this expression proﬁle might
predict microglial responsivity, and hence diﬀerential patholog-
ical outcomes under challenging conditions. To this end, we used
an optimized protocol to isolate microglia under baseline con-
ditions from small amounts of tissue based on density gradients
and ﬂuorescent-activated cell sorting (FACS), which subsequently
allowed the analysis of (inﬂammatory) gene expression proﬁles
in pure microglia derived from brain regions of relevance for PD,
e.g., the SN or other regions relevant for PD.
Materials and Methods
Animals
All experimental procedures were performed and carried out
with approval of the animal ethical committee of the VU
University Medical Center. In each independent set of exper-
iments (n = 3), two adult male Wistar rats (250 g, Harlan)
were sacriﬁced and the brain was rapidly removed and kept in
GKN/BSA buﬀer (see below) on ice.
Acute Microglia Isolation
Percoll Solutions
Percoll (GE healthcare Biosciences, Uppsala, Sweden) was diluted
1:10 in sterile 10x PBS to yield 100% isotonic Percoll. This iso-
tonic Percoll was diluted in GKN/BSA buﬀer (GKN 0.8 g/l NaCl,
0.4 g/l KCl, 3.6 g/l Na2HPO4.12H20, 0.8 g/l NaH2PO4, 2 g/l
D-(+)-glucose, 0.3% BSA; pH 7.4, 4◦C) to yield 75% and 50%
isotonic Percoll solutions.
Tissue Processing
All procedures were carried out on ice. After removal of
the meninges, OB, amygdala (AM), HC, striatum (STR) and
SN were rapidly dissected, and placed separately in a plastic
Petri dish containing 2 ml of ice-cold GKN/BSA buﬀer (see
Figure 1 for information on anatomical location of dissected
regions). Identical regions from 2 rats were pooled per exper-
iment to increase microglial yield. Tissue was minced with a
razor blade and transferred to a 70 μm pore size strainer (BD
Biosciences, Erembodegem, Belgium) on top of a 50 ml conical
tube (Greiner Bio-One). Tissue was then gently dissociated and
mashed through the strainer to reach a single cell suspension. An
additional 30 ml GKN/BSA was added to the tube containing the
cell suspension, and then the tubes were centrifuged for 10 min
at 300x g at 4◦C (Hettich, Tuttlingen, Germany).
Density Gradient Centrifugation
The supernatant was discarded and the remaining cell pellet was
resuspended in 1 ml 50% Percoll and transferred to a new 15 ml
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FIGURE 1 | Anatomical representation of dissected brain regions (adapted from the Rat Brain Atlas; https://gaidi.ca/rat-brain-atlas/). Brain regions that
were dissected for microglia isolation are indicated in blue; OB, STR, AM, HC and SN. Bregma coordinates indicate the anterior-posterior range of each region that
was dissected.
polystyrene tube after which an additional 7 ml 50% Percoll was
added. Then 4 ml of 75% Percoll was gently layered underneath
the 50% Percoll layer and subsequently 3 ml GKN/BSA buﬀer
was layered on top of the 50% Percoll layer using a Pasteur
pipette. The density gradient was centrifuged at 1300x g (Hettich,
Tuttlingen, Germany) for 30 min at 4◦C.
Microglia Collection
Two distinct layers were apparent after centrifugation. The top
layer between the GKN/BSA and 50% Percoll gradient consisted
mainly of thick, viscous myelin. The lower layer at the inter-
phase between the 50 and 75% Percoll phases appeared quite
faint and contains highly enriched microglia. First, the top layer
was carefully removed and then, using a new Pasteur pipette, the
microglia containing interphase was aspirated and transferred to
a 15 ml polystyrene tube. Cells were washed twice with 14 ml of
GKN/BSA buﬀer and after adding another 14 ml of GKN/BSA
buﬀer, the cells were centrifuged for 7 min at 300x g at 4◦C and
the buﬀer was discarded.
Fluorescence-Activated Cell Sorting (FACS)
Staining of Microglial Cells
Immediately after Percoll gradient separation and washing steps,
cells were stained with the following antibodies: Paciﬁc blue-
labeled mouse anti CD11b (Serotec, MCA275PB; ﬁnal dilution
1:30) or Alexa647-labeled mouse anti CD45 (Serotec, MCA
43A647; ﬁnal dilution 1:30), including isotype controls (IgG2a,
IgG1) to control for background staining. Brieﬂy, cells per region
were incubated for 30 min at 4◦C in antibody diluted in PBS and
shielded from light. In addition, cells were incubated for 10 min
with Sytox green nucleic acid stain (Molecular Probes, S7020;
ﬁnal dilution 1:500,000) to distinguish living from dead cells,
shortly before ﬂow cytometry. Subsequently, cells were rinsed
twice in PBS, pelleted at 1200 rpm for 5 min at 4◦C and resus-
pended in 300 μl PBS before they were ﬁltered over a 70 μm size
strainer to obtain a single cell suspension ready for FACS analysis
and sorting.
FACS Analysis and Sort of Microglia
Cell size, granularity, and ﬂuorescence intensity were ana-
lyzed per brain region (n = 3) with a MoFlo ﬂuorescent
activated cell sorter (Beckman Coulter, Mijdrecht, Netherlands).
Approximately 2x104 events were counted and subsequently
analyzed using Summit software version 4.3 (DAKO) to deter-
mine gates before cells were sorted. Microglia were deﬁned
as the percentage of all living, Sytox green negative, cells
that showed CD11bpos/CD45low expression (Sedgwick et al.,
1991). Subsequently, for each brain region, the FACS sorted
microglial cells were transferred into RNAse-free tubes
and centrifuged for 5 min at 300x g (Hettich, Tuttlingen,
Germany) at 4◦C. The supernatant was aspirated, and
cells were lysed with 500 μl Trizol reagent (Invitrogen,
Carlsbad, CA, USA) for 5 min at RT. Lysates were stored at
−80◦C for subsequent RNA isolation, cDNA synthesis and
qPCR analysis.
RNA Isolation, cDNA Synthesis and
Quantitative Real-Time PCR
Total RNA (n = 3/brain region) was isolated from sorted
microglia per brain region using Trizol Reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s instruc-
tions. Total RNA was further puriﬁed using the RNeasyMinElute
Cleanup kit (Qiagen). RNA was reverse-transcribed into cDNA
using the High-Capacity cDNA Reverse Transcription kit (Life
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Technologies), using 0.5 μg oligo-dT primers and according
to the manufacturer’s instructions. For subsequent quantita-
tive real-time PCR (qPCR), the Power SYBR Green Master
Mix (Life Technologies) was used. Primers were purchased
from Eurogentec (Maastricht, Netherlands) and qPCR was
performed in MicroAmp Optical 96-well Reaction Plates
(Applied Biosystems) on a StepOnePlus Real-Time PCR sys-
tem (Applied Biosystems). The reaction mixture (20 μl)
was composed of 1 × Power SYBR Green buﬀer (Applied
Biosystems), 3.75 pmol of each primer (see Table 1 for primer
details), and 12.5 ng cDNA. The thermal cycling condi-
tions were an initial 10 min at 95◦C followed by 40 cycles
of 15 s at 95◦ C and 1 min at 60◦C. The speciﬁcity of
the reaction was checked by means of melt curve analysis.
The relative expression level of the target genes was deter-
mined by the LinRegPCR software (version 2014.3; website:
http://www.hfrc.nl) using the following calculation N0=Nq/ECq
(N0 = target quantity, Nq = ﬂuorescence treshold value,
E = mean PCR eﬃciency per amplicon, Cq = treshold
cycle (Ruijter et al., 2009), after which the value was nor-
malized relative to glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH). We chose GAPDH as reference gene based on pre-
vious studies (Roy et al., 2006; Melief et al., 2012). Furthermore,
no in vivo or ex vivo treatments have been performed
with the cells that may change the expression of reference
genes.
Statistical Analysis
Statistical analyses were performed using the SPPS package ver-
sion 20.0 (Statistical Product and Service Solutions, Chicago, IL,
USA). The mean and SD of eﬃciency corrected and GAPDH
normalized mRNA expression in microglia were calculated for
each brain region. Since data was normally distributed, as deter-
mined by the Shapiro-Wilk test, within statistical analysis was
performed using a paired sample T-test. Bonferroni corrections
for multiple testing led to a p-value of 0.005 (alpha/number
of tests: 0.05/10). However, since this may be too stringent
for our analysis leading to type 2 errors (false negative), we
indicated the results in our graphs as signiﬁcant with p-value set
at 0.05.
Results
FACS Sorted Microglia from Various Rat
Brain Regions
For the isolation of microglia, we optimized earlier devel-
oped protocols with respect to microglia survival and purity
(Frank et al., 2006; De Haas et al., 2008; Melief et al., 2012). Upon
ﬂow cytometry, microglia were identiﬁed based on cell size,
granularity (Figure 2A, R1) and viability by Sytox green nucleic
acid staining (Figure 2B, R2). As it has been shown that in
gray matter brain regions of untreated rodents, hardly any
monocytes/macrophages can be observed (Lawson et al., 1990),
we identiﬁed a large homogeneous CD11bhigh/CD45pos cell
population which we considered being only microglia, reveal-
ing a population of 90–95% of all viable cells (mean ± SD,
Figure 2C; Table 2). A small amount (mean of 7%) of
CD11blow/CD45poscells (Figure 2C), especially observed in the
OB, were identiﬁed as lymphocytes (Lacombe et al., 1997;
Stirling and Yong, 2008). After sorting of the microglial cells,
their amount ranged from 1.1 × 104 microglial cells in the
SN to 1.2 × 105 microglial cells in the OB (Table 2). The
CD11bhigh/CD45pos expressing cells were then sorted to obtain
a pure microglia population for further analysis (Figure 2C).
Brain Region-Specific Gene Expression
To determine brain region-speciﬁc microglial expression,
microglia were sorted from the OB, SN, Str, HC, and AM,
and gene expression within these samples was analyzed by
means of qPCR. The genes chosen for analysis have been
described to be expressed in microglia in vivo or in vitro, both
under control and/or inﬂammatory conditions. We determined
clear mRNA expression of CD11b (itgam; general microglia)
and AIF-1 (iba1; general microglia), CD68 (microglial acti-
vation), TNF (pro-inﬂammatory cytokine), TLR2 (pathogen
TABLE 1 | Primer sequences used for q-PCR analysis.
Rat genes Alignment sequence Forward (5′→3′) Reverse (5′→3′) bp
GAPDH NM_017008.3 GAACATCATCCCTGCATCCA GCCAGTGAGCTTCCCGTTCA 79
GFAP NM_017009.2 CAGACTTTCTCCAACCTCCAG CTCCTGCTTCGAGTCCTTAATG 138
TNFα NM_012675.3 CCACACCGTCAGCCGATT TCCTTAGGGCAAGGGCTCTT 81
TLR2 NM_198769.2 GAGCATCGGCTGGAGGTCT CTGGAGCTGCCATCACACAC 160
ITGAM NM_012711.1 TTATTGGGGTGGGAAACGCCT CTGGAGCTGGTTCCGAATGGT 137
AIF1 NM_017196.3 GCCTCATCGTCATCTCCCCA AGGAAGTGCTTGTTGATCCCA 142
IL-1β NM_031512.2 AAAGAAGAAGATGGAAAAGCGGTT GGGAACTGTGCAGACTCAAACTC 81
CD68 NM_001031638.1 CTCATCATTGGCCTGGTCCT GTTGATTGTCGTCTGCGGG 80
NOS2 NM_012611.3 AACTTGAGTGAGGAGCAGGTTGA CGCACCGAAGATATCCTCATGA 81
MSR1 NM_0011939.1 AAAGGCAGGGAGGTCAGGATTTC CCGCTACCATCAACCAGTCG 89
P2X7R NM_001038839.1 ACCCTCAGTGTTCCATCTTCCG TTCCTCCCTGAACTGCCACC 84
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein; TNFα, tumor necrosis factor alpha; TLR2, toll-like receptor 2; ITGAM, integrin,
alpha M (CD11b); AIF1, allograft inflammatory factor 1 (Iba-1); IL-1β, interleukin-1 beta; CD68, cluster of differentiation 68; NOS2, nitric oxide synthase 2; MSR1,
macrophage scavenger receptor 1; P2X7R, P2X purinoreceptor 7 bp, amplicon size base pair.
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FIGURE 2 | Flow cytometric analysis based on cell size, granularity and
viability identified microglia with CD11bhigh/CD45pos expression.
(A) Microglia appeared homogeneous in cell size and granularity (R1). (B) Sytox
green staining, a DNA-binding dye that is actively taken up by dying cells,
distinguished the living cells (R2) from dead cells and debris. (C) Combined
selection based on cell size, granularity, and viability (R1 and R2) resulted in a
microglial purity of 92.4 ± 0.87% (mean ± SD), as identified by their
characteristic CD11bhigh/CD45pos expression. A small fraction of lymphocytes
was present to within the viable cells. To obtain a 100% pure microglial
population, microglia (R3) were sorted.
recognition), P2X purinoreceptor 7 (P2X7R; receptor for ATP),
C-C chemokines receptor 2 (CCR2; monocyte chemotaxis) and
Interleukin-1β (IL-1β; pro-inﬂammatory cytokine; Figure 3).
Macrophage scavenger receptor (MSR-1), involved in alter-
native microglial activation and phagocytosis, brain-derived
neurotrophic factor (BDNF) and inducible nitric oxide syn-
thase (NOS-2) expression levels were below the detection limit
(data not shown). Moreover, hardly any GFAP expression was
observed, indicating the absence of astrocyte contamination in
the sorted microglia (Figure 3C). Normalized mRNA expression
of the general microglial markers AIF-1 and CD11b showed
no signiﬁcant diﬀerences between the diﬀerent brain regions
studied (Figures 3A,B). There was a trend toward higher CD11b
mRNA expression level in the OB compared to Str, and in the
SN compared to the HC (Figure 3B; p = 0.059; p = 0.062,
respectively). The mRNA level of the microglial activation
marker CD68 was signiﬁcantly higher in the OB compared
to the Str, HC, and AM (Figure 3D; ∗p = 0.030, ∗p = 0.049,
∗p = 0.020, respectively), and in the Str compared to the AM
(Figure 3D; #p = 0.014). Furthermore, trends were present
toward higher CD68 mRNA levels in Str compared to HC
(Figure 3D; p = 0.075) and in HC relative to AM (Figure 3D;
p = 0.091).
Interleukin-1β mRNA expression was signiﬁcantly elevated in
the OB compared to Str (Figure 3E; ∗p = 0.034) and a trend
was observed toward more expression in the OB compared to
all other regions (Figure 3E; SN p = 0.074; HC p = 0.056; AM
p = 0.063), while TNFα mRNA level was signiﬁcantly higher
TABLE 2 | Quantification of isolated microglia per brain region.
Brain regions OB SN HC STR AM
% Pure microglia
of viable cells (R2)
95 90 91 93 93
# Sorted microglial
cells
1.2 × 105 1.1 × 104 6.5 × 104 7.2 × 104 4.3x1014
#, number; %, percentage; OB, olfactory Bulb; SN, substantia nigra; HC, hip-
pocampus; STR, striatum; AM, amygdale
in the SN compared to HC (Figure 3F; ∗p = 0.047) in addi-
tion to a trend toward more expression in the SN compared
to OB and AM (Figure 3F; p = 0.078; p = 0.068, respec-
tively). TLR2, involved in pathogen recognition, was not dif-
ferent between the diﬀerent brain regions and showed a sim-
ilar expression pattern as AIF-1 mRNA (Figure 3G). This in
contrast to CCR2, a receptor for CCL2 involved in microglial
recruitment and proliferation (Prins et al., 2014), that was sig-
niﬁcantly elevated in the SN compared to the OB (Figure 3H;
∗p = 0.027). P2X7R, a purinoreceptor for ATP, was expressed
at signiﬁcantly lower amounts in the SN compared to HC,
Str and AM (Figure 3I; ∗p = 0.015; ∗p = 0.008; ∗p = 0.040,
respectively) but signiﬁcantly higher in the HC relative to the
OB (Figure 3I; #p = 0.26). Notably, all values indicated here
are based on paired-sample t-test with a signiﬁcance set at
0.05, they did not survive Bonferroni corrections for multiple
testing (p ≤ 0.005), and therefore should be interpreted with
care.
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FIGURE 3 | Region-specific expression levels of established microglial
markers. No significant differences were found in AIF1 (A), CD11b (B) and
TLR2 (C) mRNA levels between the different brain regions. For CD68 (D)
and IL-1β (E), a significantly higher expression was present in the OB
compared to other brain regions (CD68: OB vs. Str, HC, AM ∗p < 0.05;
IL-1β: OB vs. Str ∗p < 0.05), and a significantly higher expression of CD68
(d) in Str compared to AM was found (#p < 0.02). Significantly higher TNF
mRNA level (F) was measured in the SN relative to the HC (∗p < 0.05),
a significantly higher CCR2 mRNA level (G) in SN compared to OB
(∗p < 0.05), significantly lower P2X7R mRNA level (H) in SN compared to
Str, HC, and AM (∗p < 0.05), and significantly more P2X7R expression (H)
in the HC compared to OB (#p < 0.05). (I) No GFAP expression was
observed, indicating that the sorted microglia were not contaminated by
astrocytes.
Discussion
By optimizing protocols to isolate pure microglia from several
gray matter regions implicated in PD, we could determine
brain-region speciﬁc microglial gene expression proﬁles. We
demonstrate that already under control conditions, gray matter-
derived microglial cells express markers that are essential not
only for regulating brain homeostasis, but also do so in a region-
speciﬁc manner.
For the present study, region-speciﬁc microglial gene expres-
sion was determined in Wistar rats, because this rat strain will
be used for subsequent PD-related studies. However, we can-
not exclude that the results obtained thus far in Wistar rats
may diﬀer when other rat strains, e.g., inbred strains, will be
used.
Our current isolation protocol diﬀers from other studies
that isolated microglia from adult brain using enzyme diges-
tion in order to obtain cell suspensions (Melief et al., 2013;
Orre et al., 2014). Since we avoided enzymatic digestion, this
prevented alterations in the expression of surface antigens
that are important for cell identiﬁcation (Ford et al., 1996).
Moreover, in the present study we directly analyzed freshly iso-
lated microglia, which is more representative for the in vivo
status of these cells at the time of isolation (Frank et al., 2006;
Melief et al., 2012; Olah et al., 2012). Also the isolation procedure
itself may inﬂuence the cell status, which is why all brain regions
were dissected, and the cells isolated and processed immediately
and all at the same time. The whole procedure was further per-
formed on ice to avoid microglial activation as much as possible
and biological triplicates were used to determine variability. Thus,
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when microglia isolated from one brain region show a diﬀer-
ent gene expression proﬁle from microglia isolated from another
region, such results should then reﬂect region-speciﬁc properties
of the cells.
Fluorescent-activated cell sorting analysis revealed that indeed
around 93% of all isolated cells were microglia, character-
ized by CD11bhigh/Cd45pos expression relative to lymphocytes
CD11blow/Cd45pos expression, after gating on size and granu-
larity and viability. The remaining cells consisted of lympho-
cytes. Hence, after sorting for CD11bhigh/CD45pos expressing
cells, a pure population of microglia was obtained. The num-
ber of microglial cells obtained from the various gray matter
brain regions diﬀered substantially with the lowest yield from
the SN, and the highest from the OB. This diﬀerence can be
attributed to the size of the areas excised from which cells were
isolated (Figure 1) but was controlled for during qPCR anal-
ysis. In line with previous studies, enrichment and purity of
brain microglia was conﬁrmed at the mRNA level by studying
the expression of established general microglial markers CD11b
and Iba1 in all brain regions (Ito et al., 1998; Frank et al., 2006;
Torres-Platas et al., 2014). Based on hardly detectable GFAP
mRNA levels, astrocyte contamination of the FACS sorted cells
was excluded. We further characterized regional speciﬁcity of
microglia in the healthy brain by studying the expression of
genes that have previously been reported in microglia, under
control and/or inﬂammatory conditions (Vroon et al., 2007;
Lucin and Wyss-Coray, 2009; Borrajo et al., 2014; Doorn et al.,
2014b; Prins et al., 2014).
Under healthy conditions, microglia display a ramiﬁed phe-
notype that is generally characterized by a low expression of
molecules like CD68 and MHCII, and by a low phagocytic activ-
ity (Aloisi, 2001; Perry et al., 2007; Hart et al., 2012). CD68 is
a glycoprotein which binds to low density lipoprotein and is
used as a marker for both activated, amoeboid microglia, as well
as primed microglia (Holness and Simmons, 1993; Wong et al.,
2005; Eggen et al., 2013). Its expression has furthermore been
related to aging (Perry et al., 1993; Conde and Streit, 2006). Our
results show that more CD68 expression is present in the OB
compared to other brain regions, which suggests that an acti-
vated or primed state of microglia exists in the OB, as we also
conﬁrmed with IL-1β measures. It has been shown before in
naïve mice that expression of activational markers, including
MHCII, is relatively high in parenchymal microglia (Zhang et al.,
2002) Together, this could be representative for the clear antigen-
presenting function that microglial cells can have, and with
the notion that microglia in the OB are already in a primed
state under normal conditions. This suggests that OB-derived
microglia may be more prone to priming than microglia derived
from other gray matter brain regions, which in turn may lead
to diﬀerential outcomes between diﬀerent brain regions when
confronted with pathological conditions, e.g., α-synuclein aggre-
gation.
Similar to CD68, also the pro-inﬂammatory cytokine IL-1β
was expressed at higher level in the OB relative to other regions.
IL-1β is rapidly upregulated in response to various inﬂammatory
triggers and exerts a wide range of biological and physiological
eﬀects on the immune, endocrine and nervous system (Rothwell,
1991; van Dam et al., 1992; Wang et al., 2008). Our results are
in line with previous data demonstrating that IL-1β protein is
abundantly present in the OB of rats (Lim and Brunjes, 1999). Of
interest to note is that we have demonstrated, using knock-out
mice that IL-1β contributes to microgliosis, i.e., elevated CD68
expression, in the OB, but not in the SN (Vroon et al., 2007).
Our present data thus support the notion that expression of
CD68 and IL-1β expression are related. The enhanced expres-
sion observed in the OB relative to other regions could be due to
the important role of the OB in odor discrimination in rodents.
In particular the close connections to the outside world may be
of ultimate importance for the microglial cells to be in an eas-
ily alerted state to monitor and respond to possible changes in
homeostasis.
In contrast to IL-1β and CD68, mRNA levels of TNFα were
found to be increased in the SN and to be markedly low in
the OB, relative to other brain regions. TNFα has been con-
sidered a possible key inﬂammatory regulator that can induce
cytokine production and (Sriram et al., 2002; Kraft et al., 2009).
In the CNS, microglia are the primary source of TNFα (Hanisch,
2002) and TNFα release by microglia has been implicated in
neurotoxicity (Mogi et al., 1994; Taylor et al., 2005; Borrajo et al.,
2014). Interestingly, a region-speciﬁc, but dual role for TNFα
itself has been suggested, e.g., in the brain of MPTP treated
mice. In this model, it was proposed that TNFα promotes neu-
rodegeneration in the Str but has a protective role in the HC
(Sriram et al., 2006). Here, whereas we did not ﬁnd diﬀerences in
baseline TNFα expression between HC and Str, high expression
levels were present in the SN. This increase in TNFα expression
in the SN under normal conditions may underlie the increased
neuronal vulnerability seen in the SN following additional chal-
lenges, such as during the development of α-synuclein pathology
(Watson et al., 2012). A protein typically known to be involved
in oxidative cell stress responses is NOS-2. Since we could not
detect NOS-2 in microglia derived from various brain regions,
this supports the notion that the naïve rats we used did not
experience cell stress, and that experimental handling condi-
tions of our samples did not induce oxidative stress in the cells
either.
To further characterize microglial cell diﬀerences between
diﬀerent brain regions, we investigated their expression levels
of several receptors. TLR2, a receptor for pathogen recogni-
tion, was recently implicated in the activation of microglia by
α-synuclein in vitro (Beraud et al., 2011; Kim et al., 2013) and is
thought to stimulate secretion of pro-inﬂammatory cytokines.
Moreover, in tissue of PD patients, diﬀerences in TLR2 expres-
sion were found in microglia by us between the HC and SN of PD
patients (Doorn et al., 2014b). Also overexpression of α-synuclein
in rodents was reported to increase TLR2 mRNA speciﬁcally in
the SN but not in other regions (Watson et al., 2012). However,
in our current study using naïve rats, no diﬀerences were present
in microglial TLR2 mRNA levels between the regions studied.
This supports the idea that TLR2 is distributed in an evenly
manner throughout the brain under normal conditions, and is
mainly upregulated by microglia when they encounter speciﬁc
pathogens, like α-synuclein, and as such, does not represent a
marker for primed microglia.
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Clear diﬀerences were found in CCR2 mRNA expression
levels that were higher in the SN than in other gray matter
regions. CCR2 is implicated in leukocyte migration and has
recently been shown to be expressed by gray matter microglial
cells and to be involved in cell proliferation (Hinojosa et al.,
2011; Prins et al., 2014). In agreement, CCR2 deﬁciencymarkedly
impaired microglial recruitment, accelerated β-amyloid accumu-
lation and disease progression in a mouse model for Alzheimer’s
disease (AD; El Khoury et al., 2007). Hence, the higher expres-
sion of CCR2 mRNA already at basal conditions in the SN
could similarly be beneﬁcial for microglial recruitment when
homeostasis becomes disturbed. In contrast to AD, microglial
recruitment in the SN is often associated with an aversive envi-
ronment that could promote DA-ergic vulnerability to cell death
in PD (Kim et al., 2000). The related high expression of TNFα in
the SN (present study) thus supports an enhanced sensitivity of
the SN to neurotoxicity.
As member of the purinergic receptor family, P2X7Rs are a
class of ligand-gated ion channels activated by ATP that con-
tributes to neuro- and glio-transmission. P2X7Rs are expressed
by both neurons and glia in various brain regions and have
been implicated in a wide variety of behaviors, including learn-
ing and memory (Chu et al., 2010; Burnstock et al., 2011) These
receptors have also been described to be involved in responses
to trauma, neurodegeneration, neuropsychiatric disorders and
neuropathic pain (McLarnon et al., 2006; Burnstock et al., 2011;
Carmo et al., 2014). Especially, the fast purinergic synaptic trans-
mission that is in part mediated through these receptors, has been
clearly identiﬁed (Pankratov et al., 2009) in a number of brain
areas, including the HC (Mori et al., 2001; Pankratov et al., 2002).
The higher P2X7R mRNA in the HC compared to other regions
as observed in the present study could contribute to its role in
regulating synaptic plasticity and memory formation in the HC
(Wieraszko, 1996; Campos et al., 2014); this is likely an indirect
eﬀect via microglial cells (Chu et al., 2010). Alternatively, P2X7R
on microglial cells are implicated in ATP-mediated microglial
activation and cytokine release, of importance for brain disor-
ders (Ni et al., 2013; Shieh et al., 2014). In addition, ATP-P2X7R
signaling is involved in glial cell proliferation (Zou et al., 2012)
which is apparent in the HC of presymptomatic PD patients
(Doorn et al., 2014a). Thus, P2X7R in the HC has strategic impli-
cations for monitoring deviations in ATP levels resulting in
cell proliferation and plasticity changes that likely contribute to
adaptive behavior seen under disease conditions like PD.
Based on transcriptional proﬁling, proteomics and functional
assays, microglia are typically classiﬁed into ‘classically’ acti-
vated microglia (M1 type) or ‘alternatively’ activated microglia
(M2 type; Mantovani et al., 2004; Mosser and Edwards, 2008;
Gordon and Martinez, 2010). M1 microglia are polarized by
IFN-γ and then produce pro-inﬂammatory cytokines (e.g.,
IL-12, IL-1β, TNFα) and oxidative metabolites that can cause
cytotoxicity. In contrast, IL-4, IL-10, and IL-13 polarize
M2 microglia, which then downregulate pro-inﬂammatory
cytokines, increase their expression of anti-inﬂammatory
molecules and facilitate wound healing and repair, also
within the damaged CNS (Mantovani et al., 2002; Kigerl et al.,
2009; Gordon and Martinez, 2010; David and Kroner, 2011;
Doorn et al., 2012). MSR1 and BDNF are proteins expressed
by alternative activation of microglia and are related to growth
factors, anti-inﬂammatory cytokine production and neuropro-
tection (Mantovani et al., 2002; Lucin and Wyss-Coray, 2009).
The fact that these sets of genes were undetectable in our
current study, whereas genes related to the classical activa-
tion state of microglia, e.g., CD68, IL-1β and TNFα were
present, suggests that the brain region-speciﬁc diﬀerences in
microglia gene expression proﬁle under healthy conditions are
more related to the classical activation pathway in these cells.
This implies that genes expressed by alternatively activated
microglia would become more important when homeosta-
sis is derailed, but would remain undetectable under naïve
conditions.
Conclusion
The present data demonstrate that a unique basal gene expres-
sion signature of microglia exists that diﬀers between diﬀerent
gray matter brain regions of Wistar rats. Within the local brain
microenvironment, glial cells play critical roles in the homeo-
static mechanisms that support neuronal survival. Since the basal
proﬁle of microglia is more tuned toward a pro-inﬂammatory
proﬁle and in a region-dependent way, such region-speciﬁc
gene expression proﬁles of microglia likely predict diﬀerent out-
comes under challenging and disease conditions. As such, region-
speciﬁc diﬀerences in neuronal susceptibility in conditions like
PD, could at least in part, be attributable to basal diﬀerences in
levels of inﬂammation-related receptors and other factors that are
endogenously, and diﬀerentially, produced by microglial cells.
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